Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that an oral ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

This time of year is also typically when we see higher infection rates of both COVID-19 and Respiratory Syncytial Virus, or RSV. If you come down with a cough or a fever, you might be wondering ...

But with COVID-19, the flu, respiratory syncytial virus, or RSV, and just the common cold all floating around and all sharing several similar symptoms, how are you supposed to know what you might ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

at the 13 th International RSV Symposium, occurring March 12-15 in Iguazu, Brazil. The data to be presented includes analyses of the company’s completed Phase 1 study in adults as well as its ...

Just like with cold and flu, there's also a respiratory syncytial virus (RSV) season. Find out when you're more at risk and how to protect yourself.

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

The surge in flu cases also comes amid concerns about high infection rates for other viruses including RSV, COVID-19 and the gastrointestinal bug norovirus. Still, health officials say flu cases ...

Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium Blue Lake Biotechnology, Inc., a clinical-stage ...